Alan C. Rapraeger

Also affiliated with Wisconsin Division of Public Health

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Ponatinib sensitizes myeloma cells to MEK inhibition in the high-risk VQ model”.

Ponatinib sensitizes myeloma cells to MEK inhibition in the high-risk VQ model

Scientific Reports(2022)10.1038/s41598-022-14114-z

N/A

0.416DataRank · unranked

15 citations

Zhi Wen, Adhithi Rajagopalan, Oisun Jung, Lyndsay Watkins, Joshua Wiesner +10 more

Syndecans and Their Synstatins: Targeting an Organizer of Receptor Tyrosine Kinase Signaling at the Cell-Matrix Interface

Frontiers in Oncology(2021)10.3389/fonc.2021.775349

N/A

0DataRank · unranked

18 citations

Alan C. Rapraeger

Plasma membrane proteoglycans syndecan-2 and syndecan-4 engage with EGFR and RON kinase to sustain carcinoma cell cycle progression

Journal of Biological Chemistry(2022)10.1016/j.jbc.2022.102029

N/A

0DataRank · unranked

10 citations

Scott E. Nelson, Kristin M. Adams, Noah A. Stueven, Oisun Jung, Alan C. Rapraeger +1 more

Ponatinib for RAS-Driven Multiple Myeloma: Efficacy in the High-Risk VQ Myeloma Model

Research Square(2022)10.21203/rs.3.rs-1296881/v1

N/A

0DataRank · unranked

0 citations

Zhi Wen, Adhithi Rajagopalan, Oisun Jung, Joshua Wiesner, Xiaona You +8 more